{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:07:42Z","timestamp":1761156462276},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0233-1","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T08:22:01Z","timestamp":1521015721000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective study"],"prefix":"10.1186","volume":"16","author":[{"given":"Alexandra","family":"Okihiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Hasija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillia","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayfel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae S. M.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley M. L.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"233_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1546-0096-12-13","volume":"12","author":"ML Stoll","year":"2014","unstructured":"Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014;12:13.","journal-title":"Pediatr Rheumatol Online J"},{"key":"233_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.berh.2014.03.005","volume":"28","author":"EA Kessler","year":"2014","unstructured":"Kessler EA, Becker ML. Therapeutic advancements in juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol. 2014;28:293\u2013313.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"233_CR3","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/art.27511","volume":"62","author":"P Diak","year":"2010","unstructured":"Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum. 2010;62:2517\u201342.","journal-title":"Arthritis Rheum"},{"key":"233_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/1471-2407-14-634","volume":"14","author":"VC Kok","year":"2014","unstructured":"Kok VC, Horng JT, Huang JL, Yeh KW, Gau JJ, Chang CW, et al. Population-based cohort study on the risk of malignancy in east Asian children with juvenile idiopathic arthritis. BMC Cancer. 2014;14:634.","journal-title":"BMC Cancer"},{"key":"233_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12969-016-0066-8","volume":"14","author":"S Barth","year":"2016","unstructured":"Barth S, Schlichtiger J, Bisdorff B, H\u00fcgle B, Michels H, Radon K, et al. Association between drug intake and incidence of malignancies in patients with juvenile idiopathic arthritis: a nested case\u2013control study. Pediatr Rheumatol Online J. 2016;14:6.","journal-title":"Pediatr Rheumatol Online J"},{"key":"233_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/rheumatology\/ket318","volume":"53","author":"N Ruperto","year":"2014","unstructured":"Ruperto N, Martini A. Juvenile idiopathic arthritis and malignancy. Rheumatology (Oxford). 2014;53:968\u201374.","journal-title":"Rheumatology (Oxford)"},{"key":"233_CR7","first-page":"1681","volume":"35","author":"IL Hodgkin","year":"2008","unstructured":"Hodgkin IL. S lymphoma associated with anti-tumor necrosis factor use in juvenile idiopathic arthritis: supplemental case report. J Rheumatol. 2008;35:1681.","journal-title":"J Rheumatol"},{"key":"233_CR8","first-page":"1680","volume":"35","author":"C Yildirim-Toruner","year":"2008","unstructured":"Yildirim-Toruner C, Kimura Y, Hodgkin RCE. S lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis. J Rheumatol. 2008;35:1680\u20131.","journal-title":"J Rheumatol"},{"key":"233_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1546-0096-8-18","volume":"8","author":"P McCroskery","year":"2010","unstructured":"McCroskery P, Wallace CA, Lovell DJ, Stryker S, Chernyukhin N, Blosch C, et al. Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatr Rheumatol Online J. 2010;8:18.","journal-title":"Pediatr Rheumatol Online J"},{"key":"233_CR10","doi-asserted-by":"publisher","first-page":"e000212","DOI":"10.1136\/rmdopen-2015-000212","volume":"2","author":"ZO Niaki","year":"2016","unstructured":"Niaki ZO, Clarke AE, Ramsey-Goldman R, Yeung R, Hayward K, Oen K, et al. Malignancy incidence in 5294 patients with juvenile arthritis. RMD Open. 2016;2:e000212.","journal-title":"RMD Open"},{"issue":"4","key":"233_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3899\/jrheum.100711","volume":"38","author":"S Bernatsky","year":"2011","unstructured":"Bernatsky S, Rosenberg AM, Oen KG, Duffy CM, Ramsay-Goldman R, Labrecque J, et al. Malignancies in juveniole idiopatic arthritis: a preliminary report. J Rheumatol. 2011;38(4):760\u20133.","journal-title":"J Rheumatol"},{"issue":"4","key":"233_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/archderm.1973.01620250020004","volume":"108","author":"FW Moehlenbeck","year":"1973","unstructured":"Moehlenbeck FW. Pilomatrixoma (Calcifying epithelioma). A statistical study. Arch Dermatol. 1973;108(4):532\u20134.","journal-title":"Arch Dermatol"},{"issue":"2","key":"233_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/pbc.22521","volume":"55","author":"I Sultan","year":"2010","unstructured":"Sultan I, Casanova M, Ferrari A, Rihani R, Rodriguez-Galindo C. Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr Blood Cancer. 2010;55(2):279\u201384.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"233_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/pbc.21779","volume":"52","author":"J Silberstein","year":"2009","unstructured":"Silberstein J, Grabowski J, Saltzstein SL, Kane CJ. Renal cell carcinoma in the pediatric population: results from the California cancer registry. Pediatr Blood Cancer. 2009;52(2):237\u201341.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"233_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/adc.86.1.47","volume":"86","author":"AG Cleary","year":"2002","unstructured":"Cleary AG, McDowell H, Sills JA. Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin\u2019s lymphoma. Arch Dis Child. 2002;86(1):47\u20139.","journal-title":"Arch Dis Child"},{"key":"233_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11926-012-0310-2","volume":"15","author":"ML Mannion","year":"2013","unstructured":"Mannion ML, Beukelman T. What is the background incidence of malignancy in children with rheumatic disease? Curr Rheumatol Rep. 2013;15:310.","journal-title":"Curr Rheumatol Rep"},{"key":"233_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/art.34348","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64:1263\u201371.","journal-title":"Arthritis Rheum"},{"key":"233_CR18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/acr.21709","volume":"64","author":"BL Nordstrom","year":"2012","unstructured":"Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents. Arthritis Care Res. 2012;64:1357\u201364.","journal-title":"Arthritis Care Res"},{"key":"233_CR19","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1002\/art.27741","volume":"62","author":"JF Simard","year":"2010","unstructured":"Simard JF, Neovius M, Hagelberg S, Askling J. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. Arthritis Rheum. 2010;62:3776\u201382.","journal-title":"Arthritis Rheum"},{"key":"233_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","volume":"88","author":"E Thomas","year":"2000","unstructured":"Thomas E, Brewster DH, Black RJ, Macfarlance GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer. 2000;88:497\u2013502.","journal-title":"Int J Cancer"},{"issue":"8","key":"233_CR21","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1053\/j.gastro.2017.02.004","volume":"152","author":"JS Hyams","year":"2017","unstructured":"Hyams JS, Dubinsky MC, Baldassano RN, Colletti RB, Cucchiara S, Escher J, et al. Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease. Gastroenterology. 2017;152(8):1901\u201314.","journal-title":"Gastroenterology"},{"issue":"3","key":"233_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1185\/03007995.2015.1011778","volume":"31","author":"H Lebrec","year":"2015","unstructured":"Lebrec H, Ponce R, Preston BD, Iles J, Born TL, Hooper M. Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk. Curr Med Res Opin. 2015;31(3):557\u201374.","journal-title":"Curr Med Res Opin"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-018-0233-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T20:16:37Z","timestamp":1552508197000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0233-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0233-1","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"22 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research study was approved by the Research Ethics Board, SickKids, Toronto. (REB Approval number: 1000011283).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"REB approval and consent for publication obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no disclosures nor competing of interests related to the current research study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}